Norgine Ventures

Norgine Ventures is a private investment firm established in 2012 to diversify Norgine's activities and foster innovation in the healthcare sector. It provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, primarily in Europe and the United States. Backed by Norgine, a fully integrated, private European healthcare company with over 100 years of experience in the pharmaceutical space, Norgine Ventures leverages Norgine's technical capabilities for evaluating investment opportunities, focusing on achieving financial returns rather than funding opportunities of strategic interest to Norgine.

The firm specializes in providing financing solutions to innovative healthcare companies, offering support across various stages of development, including early-stage, growth, and late-stage investments. Norgine Ventures has a broad geographical focus, investing in countries such as the United States, United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Sweden, Denmark, Norway, Finland, Ireland, Austria, Switzerland, Luxembourg, Portugal, Greece, Poland, and the Czech Republic. The industries targeted by Norgine Ventures encompass healthcare, life sciences, pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, healthcare services, consumer health, medical research, clinical trials, regulatory affairs, health insurance, healthcare IT, and healthtech.

Norgine Ventures' investment sizes range from a minimum of $1 million to a maximum of $50 million, providing flexible financing solutions tailored to the needs of innovative healthcare companies. The firm's strategic approach combines Norgine's extensive industry experience with a focus on delivering financial returns, positioning Norgine Ventures as a key player in supporting the growth and development of healthcare innovations across its target regions and sectors.